Imipramine (or TOFRANIL®) is mainly prescribed to treat major depressive disorder and enuresis.
Class: Tricyclic (TCA)
FDA Approval: 1976
Dosage Forms: 10 mg, 25 mg, 50 mg, 75 mg, 100 mg, 125 mg, 150 mg
Biological Half-life: 20 hours
Side Effects: Dizziness, nausea, blurred vision, confusion, headache, anxiety, weakness, insomnia, increased appetite, tachycardia, high blood pressure, skin rash, increased suicide risk
Routes of Administration: Oral, IM
Pregnancy Category: N (US)